Cardiovascular risk markers in women with metabolic syndrome at the menopausal transition using multimodal non-drug therapies
Aim. To study the effect of non-drug strategies on the main markers of cardiovascular risk in women with menopausal disorders and metabolic syndrome (MS).Material and methods. Three hundred women aged 45-50 years with disorders during the menopausal transition and MS were ranked in 5 groups. In grou...
Saved in:
| Main Authors: | R. R. Berikhanova, I. A. Minenkoa, S. A. Bondarev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2020-07-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3804 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endothelial dysfunction as the main component of menopausal syndrome and cardiovascular diseases
by: D. D. Keshikova, et al.
Published: (2023-07-01) -
Possibilities of non-drug correction of menopausal disorders in women with metabolic syndrome: focus on prothrombogenic potential of the blood and pro-inflammatory status
by: R. R. Berihanova, et al.
Published: (2019-05-01) -
Phytoestrogens in treatment of climacteric syndrome as an alternative to menopausal hormone therapy
by: M. I. Mazitova, et al.
Published: (2021-01-01) -
New possibilities of arterial hypertension therapy for women in menopause
by: V. N. Shishkova, et al.
Published: (2021-06-01) -
Cardiovascular system status in women with severe climacteric syndrome
by: N. V. Izmozherova, et al.
Published: (2007-02-01)